Literature DB >> 31102300

Calcium-activated nucleotidase 1 silencing inhibits proliferation, migration, and invasion in human clear cell renal cell carcinoma.

Xin Liu1, Zhenxing Yang1, Xing Luo1, Jing Luo1, Weihua Fu1, Zhenqiang Fang1, Ding Xia2, Longkun Li1, Jie Xu1.   

Abstract

Calcium-activated nucleotidase 1 (CANT1, belongs to the apyrase family, is widely expressed in various organs. However, the biological function of CANT1 remains poorly explored. In this study, we aimed to investigate the expression profile and functions of CANT1 in clear cell renal cell carcinoma (ccRCC). Our data show that the protein level of CANT1 was significantly higher in tumor tissues than in adjacent normal tissues. CANT1 silencing suppressed cell proliferation, migration, and invasion obviously in 769-P and 786-O cells, arrested cell cycle in S phase and promoted apoptosis in 769-P cells. In conclusion, the present study shows the different expression mode of CANT1 in human ccRCC tumor tissue and adjacent normal tissue, denotes the function of CANT1 in ccRCC cells and provides potential molecular mechanisms and pathways of CANT1 antitumor function in ccRCC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; calcium-activated nucleotidase 1; cell cycle; clear cell renal cell carcinoma; proliferation

Mesh:

Substances:

Year:  2019        PMID: 31102300     DOI: 10.1002/jcp.28829

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Gαi1 Promoted Proliferation, Migration and Invasion via Activating the Akt-mTOR/Erk-MAPK Signaling Pathway in Renal Cell Carcinoma.

Authors:  Zhan Chen; Yong Zhang; Xiang Wu; Ji Zhang; Wei Xu; Cheng Shen; Bing Zheng
Journal:  Onco Targets Ther       Date:  2021-05-04       Impact factor: 4.147

2.  CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro.

Authors:  Qiwei Yao; Yilin Yu; Zhiping Wang; Mengyan Zhang; Jiayu Ma; Yahua Wu; Qunhao Zheng; Jiancheng Li
Journal:  BMC Cancer       Date:  2022-01-28       Impact factor: 4.430

3.  A pharmacophore-based classification better predicts the outcomes of HER2-negative breast cancer patients receiving the anthracycline- and/or taxane-based neoadjuvant chemotherapy.

Authors:  Xuan Li; Hefen Sun; Qiqi Liu; Yang Liu; Yifeng Hou; Wei Jin
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

4.  Identifying the pattern of immune related cells and genes in the peripheral blood of ischemic stroke.

Authors:  Zijian Li; Yueran Cui; Juan Feng; Yanxia Guo
Journal:  J Transl Med       Date:  2020-08-03       Impact factor: 5.531

5.  Calcium-activated nucleotides 1 (CANT1)-driven nuclear factor-k-gene binding (NF-ĸB) signaling pathway facilitates the lung cancer progression.

Authors:  Fangfang Gao; Xiufeng Hu; Wenjing Liu; Hongbo Wu; Yu Mu; Yanqiu Zhao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

6.  A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.

Authors:  Yating Zhan; Rongrong Zhang; Chunxue Li; Xuantong Xu; Kai Zhu; Zhan Yang; Jianjian Zheng; Yong Guo
Journal:  Cancer Med       Date:  2021-07-21       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.